Ryzodeg combination injection FlexTouch, manufactured by Novo Nordisk Pharma, contains insulin degludec and insulin aspart, which are genetically recombined insulins. This injectable medication, YJ code 2492500G1025, is a soluble insulin product combining basal and rapid-acting insulin, supplied as 300 units per kit.
Ryzodeg combination injection FlexTouch
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).